Organ support & nutrition

Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill acute kidney injury (AKI) survivors

J Crit CarePublished Retrospective cohort study

Main findingResult — go to the resultWeighted adjusted odds ratio 0.68 95% CI 0.47–0.97

Authors' conclusion

Adjusted for potential confounders, the odds of RRT dependence at 90 days postdischarge among survivors of RRT for AKI was 30% lower for those treated first with CRRT vs. IHD, overall and in several sensitivity analyses.

Study context

Population
Adult intensive care units (ICU) patients discharged alive after RRT for AKI, US Premier PINC AI Healthcare Database, January 1, 2018 to June 30, 2021
Participants
3,804 patients · 382 hospitals
Exposure
Initial continuous renal replacement therapy (CRRT) vs intermittent hemodialysis (IHD)
  • CRRTn = 1,064
  • IHDn = 2,740reference
Outcome
RRT dependence (≥2 RRT treatments in the last 8 days)
Follow-up
90 days postdischarge
Methodological detailsinverse probability treatment weighting, claims-linked hospital discharge database
  • Inverse probability treatment weighting
  • Claims-linked hospital discharge database

Main finding

As reported in the abstract

Weighted adjusted odds ratio

0.68

95% CI 0.47–0.97

P = 0.03

By group

CRRT vs IHD
weighted aOR 0.68 (95% CI 0.47–0.97); P = 0.03

Observational data: associations, not effects.

Further findings

RRT dependence at hospital discharge

P = 0.04

Sensitivity analyses (including deaths days 1-90, n = 112; excluding IHD-only hospitals, n = 335; excluding modality switchers, n = 451)

Results persisted

Original publication

Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors. J Crit Care. Published 8 March 2024. doi:10.1016/j.jcrc.2024.154764

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.